First Trimester Hemoglobin A1c Prediction of Gestational Diabetes

Abstract

Objective The objective of this study is to examine whether a first trimester hemoglobin A1c (A1C) of 5.7 to 6.4% predicts an abnormal second trimester oral glucose tolerance test (OGTT).

Methods We conducted a retrospective cohort study of all women screened with A1C through 13 ^6/7 weeks' gestation between January 1, 2011, and December 31, 2012. Prediabetic women (A1C of 5.7–6.4%) were compared with women with a normal first trimester A1C (< 5.7%). The primary outcome was an abnormal 2-hour, 75-g OGTT as defined by the International Association of Diabetes and Pregnancy Study Groups.

Results There were 2,812 women who met inclusion criteria of whom 6.7% (n = 189) were prediabetic. Women with prediabetes were more likely to have gestational diabetes mellitus (GDM) even after adjusting for potential confounders (29.1 vs. 13.7%; adjusted relative risk, 1.48; 95% confidence interval, 1.15–1.89). There were no statistically significant differences in secondary outcomes except that women with prediabetes had less excessive gestational weight gain. A prediabetic-range A1C in the first trimester was associated with a 13% sensitivity and a 94% specificity for predicting GDM

Conclusion Although women with prediabetes by first trimester A1C are significantly more likely to have GDM, the low sensitivity of an A1C in this range renders it a poor test to identify women who will develop GDM.

Keywords

gestational diabetes - prediabetes - hemoglobin A1c - oral glucose tolerance test

• References

• 1 International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32 (7) 1327-1334
• 2 Hanas R, John G ; International HBA1c Consensus Committee. 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 2010; 33 (8) 1903-1904
• 3 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl. 01) S62-S69
• 4 Gregg EW, Geiss L, Zhang P, Zhuo X, Williamson DF, Albright AL. Implications of risk stratification for diabetes prevention: the case of hemoglobin A1c. Am J Prev Med 2013; 44 (4) (Suppl. 04) S375-S380
• 5 Knowler WC, Barrett-Connor E, Fowler SE , et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346 (6) 393-403
• 6 Metzger BE, Gabbe SG, Persson B , et al; International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 676-682
• 7 Guidelines for Diagnosis of Hyperglycemia in Pregnancy – 2011 [Internet] . Available at: http://www.cdappsweetsuccess.org/Portals/0/Documents/2011%20DX%20Algorithm.pdf . Cited April 18, 2015
• 8 Catalano PM. Carbohydrate metabolism and gestational diabetes. Clin Obstet Gynecol 1994; 37 (1) 25-38
• 9 Fong A, Serra AE, Gabby L, Wing DA, Berkowitz KM. Use of hemoglobin A1c as an early predictor of gestational diabetes mellitus. Am J Obstet Gynecol 2014; 211 (6) 641.e1-641.e7
• 10 Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003; 3 (1) 6
• 11 Rasmussen KM, Yaktine AL. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC: National Academies Press; 2009: 1-4
• 12 Li N, Liu E, Guo J , et al. Maternal prepregnancy body mass index and gestational weight gain on pregnancy outcomes. PLoS ONE 2013; 8 (12) e82310
• 13 Katon J, Williams MA, Reiber G, Miller E. Antepartum A1C, maternal diabetes outcomes, and selected offspring outcomes: an epidemiological review. Paediatr Perinat Epidemiol 2011; 25 (3) 265-276
• 14 Hughes RCE, Moore MP, Gullam JE, Mohamed K, Rowan J. An early pregnancy HbA1c ≥5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care 2014; 37 (11) 2953-2959
• 15 Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med 2014; 160 (8) 517-525
• 16 Kiefer MM, Silverman JB, Young BA, Nelson KM. National patterns in diabetes screening: data from the National Health and Nutrition Examination Survey (NHANES) 2005-2012. J Gen Intern Med 2015; 30 (5) 612-618
• 17 Banerjee D, Chung S, Wong EC, Wang EJ, Stafford RS, Palaniappan LP. Underdiagnosis of hypertension using electronic health records. Am J Hypertens 2012; 25 (1) 97-102
• 18 Coustan DR, Lowe LP, Metzger BE, Dyer AR ; International Association of Diabetes and Pregnancy Study Groups. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. Am J Obstet Gynecol 2010; 202 (6) 654.e1-654.e6
• 19 HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58 (2) 453-459
• 20 Langer O, Umans JG, Miodovnik M. Perspectives on the proposed gestational diabetes mellitus diagnostic criteria. Obstet Gynecol 2013; 121 (1) 177-182
• 21 Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R. Gestational diabetes mellitus diagnosed during early pregnancy. Am J Obstet Gynecol 2000; 182 (2) 346-350
• 22 Most OL, Kim JH, Arslan AA, Klauser C. Maternal and neonatal outcomes in early glucose tolerance testing in an obstetric population in New York city. J Perinat Med 2009; 37 (2) 114-117